|
KIAA1432 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.518200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.059900E-02 |
| Normal-vs-Stage2 |
8.541800E-01 |
| Normal-vs-Stage3 |
3.006400E-01 |
| Normal-vs-Stage4 |
4.828600E-01 |
| Stage1-vs-Stage2 |
2.517800E-01 |
| Stage1-vs-Stage3 |
9.294200E-01 |
| Stage1-vs-Stage4 |
8.172600E-01 |
| Stage2-vs-Stage3 |
3.405600E-01 |
| Stage2-vs-Stage4 |
4.584000E-01 |
| Stage3-vs-Stage4 |
8.103600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.446200E-01 |
| Normal-vs-AfricanAmerican |
5.431000E-01 |
| Normal-vs-Asian |
8.848100E-02 |
| Caucasian-vs-AfricanAmerican |
8.050000E-01 |
| Caucasian-vs-Asian |
5.450400E-01 |
| AfricanAmerican-vs-Asian |
4.920800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.105900E-02 |
| Normal-vs-Female |
2.665400E-01 |
| Male-vs-Female |
1.268300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.298600E-01 |
| Normal-vs-Extreme_Weight |
1.139550E-02 |
| Normal-vs-Obese |
8.919000E-01 |
| Normal-vs-Extreme_Obese |
4.012800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.082000E-01 |
| Normal_Weight-vs-Obese |
3.581400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.490800E-01 |
| Extreme_Weight-vs-Obese |
2.908200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.154800E-01 |
| Obese-vs-Extreme_Obese |
4.132200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.797200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.165600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.722400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.240700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.179000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.092440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.459500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.048300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.105600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.722000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.625800E-01 |
| Normal-VS-Type2 PRCC |
1.507540E-02 |
| Normal-VS-KIRP CIMP |
1.709970E-01 |
| Normal-VS-Unclassified PRCC |
5.865600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.949600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.199970E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.201800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.201900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.835700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.390600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.550080E-02 |
| Normal-vs-N1 |
7.089000E-01 |
| Normal-vs-N2 |
8.956500E-02 |
| N0-vs-N1 |
4.388000E-01 |
| N0-vs-N2 |
7.319200E-01 |
| N1-vs-N2 |
6.046000E-01 |
|
|
